and safety profile Promising progression free survival median 4.33 months and overall survival median 15.97 months Patients with unmethylated MGMT have a worse response to therapy than methylated MGM.#Early evidence indicates that the combination of 131I-IPA and XRT may have an anti-neoplastic effect...
我们通常所说的双倍IPA指的是()A.酒花双倍B.酒精双倍C.酒花、酒精都双倍D.苦度双倍点击查看答案&解析 手机看题 你可能感兴趣的试题 单项选择题 目前全世界90%的啤酒属于() A.拉格B.艾尔C.野菌D.世涛 点击查看答案&解析 手机看题 多项选择题 以下哪些选项符合美国精酿协会对精酿啤酒要求的定义?() A...
The objective of IPAX-2 (NCT05450744) is to evaluate the safety and tolerability of [131I]IPA in patients newly diagnosed with GBM. METHODS. IPAX-2 is a phase 1, multicenter, open-label, single-arm, parallel-group, dose-finding study to evaluate the safety of ascending radioactive dose...
Disclosure: IPAX-1 was sponsored by Telix Pharmaceuticals. IPAX Linz is an investigator-initiated trial; IMP was provided by Telix Pharmaceuticals.doi:10.1093/neuonc/noae144.170J PichlerA LeibetsederI HllmüllerJ FeichtingerJ DiernederO Osipova...
IPAX-1 was a multicenter, open-label, single-arm phase I study to evaluate carrier-added 4-L-[131I]iodo-phenylalanine ([131I]IPA) plus external radiation therapy (XRT) in recurrent GBM. METHODS. A total of 10 adults with recurrent GBM who had received first-line debulking surgery plus ...
Simultaneous quantification of regional myocardial fatty acid metabolism ( 131I-PHIPA 3–10) and perfusion ( 99mTc-MIBI)X-ray microscopycomputerised tomographyinspectionmedical image processing3D inspectionX-ray tomography imagesfabrication-degradation processes...